These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 19138798)

  • 1. Placental stress and pre-eclampsia: a revised view.
    Redman CW; Sargent IL
    Placenta; 2009 Mar; 30 Suppl A():S38-42. PubMed ID: 19138798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
    Foidart JM; Schaaps JP; Chantraine F; Munaut C; Lorquet S
    J Reprod Immunol; 2009 Nov; 82(2):106-11. PubMed ID: 19853925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New insights into the pathogenesis of pre-eclampsia: the role of angiogenesis-inhibiting factors].
    Verdonk K; Visser W; Steegers EA; Kappers M; Danser AH; van den Meiracker AH
    Ned Tijdschr Geneeskd; 2011; 155():A2946. PubMed ID: 21486506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and pre-eclampsia.
    Borzychowski AM; Sargent IL; Redman CW
    Semin Fetal Neonatal Med; 2006 Oct; 11(5):309-16. PubMed ID: 16828580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
    Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
    Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New insights in the pathophysiology of preeclampsia and potential therapeutic implications].
    Boulanger H; Flamant M
    Nephrol Ther; 2007 Dec; 3(7):437-48. PubMed ID: 18047998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia.
    Liu X; Deng Q; Luo X; Chen Y; Shan N; Qi H
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3776-85. PubMed ID: 26809169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
    Palmer KR; Tong S; Kaitu'u-Lino TJ
    Mol Hum Reprod; 2017 Feb; 23(2):69-78. PubMed ID: 27986932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aetiology and physiopathology of preeclampsia and related forms.
    Lorquet S; Pequeux C; Munaut C; Foidart JM
    Acta Clin Belg; 2010; 65(4):237-41. PubMed ID: 20954461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm?
    Ahmed A; Ramma W
    Br J Pharmacol; 2015 Mar; 172(6):1574-86. PubMed ID: 25303561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia.
    Charnock-Jones DS
    J Reprod Immunol; 2016 Apr; 114():81-5. PubMed ID: 26228018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of preeclampsia.
    Mutter WP; Karumanchi SA
    Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal distribution of small ubiquitin-like modifiers during human placental development and in response to oxidative and inflammatory stress.
    Baczyk D; Audette MC; Coyaud E; Raught B; Kingdom JC
    J Physiol; 2018 May; 596(9):1587-1600. PubMed ID: 29468681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabor Than Award Lecture 2008: pre-eclampsia - from placental oxidative stress to maternal endothelial dysfunction.
    Cindrova-Davies T
    Placenta; 2009 Mar; 30 Suppl A():S55-65. PubMed ID: 19118896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the mechanism for poor placentation in early-onset preeclampsia: the role of autophagy in trophoblast invasion and vascular remodeling.
    Saito S; Nakashima A
    J Reprod Immunol; 2014 Mar; 101-102():80-88. PubMed ID: 23969229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
    De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
    Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should women with pre-eclampsia be followed up? New insights from mechanistic studies.
    Hertig A; Watnick S; Strevens H; Boulanger H; Berkane N; Rondeau E
    Nat Clin Pract Nephrol; 2008 Sep; 4(9):503-9. PubMed ID: 18628742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
    Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
    Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.